Infants delivered by C-section are known to carry a distinct gut microbiome that increases their risk of allergies, asthma, and…
Browsing: Clinical Updates
The gut-skin axis (GSA) is emerging as a key player in linking gastrointestinal health to dermatological diseases through immune, metabolic,…
Guardant Health and Quest Diagnostics have struck a multi-year deal to make Shield™, the first FDA-approved blood test for colorectal…
Type 1 diabetes treatment is undergoing its most dramatic transformation in a century. For the first time, disease-modifying therapies like…
GLP-1 receptor agonists like Ozempic and Trulicity, now staples in diabetes and obesity care, are presenting new challenges in colonoscopy…
Roche is making a big bet on fatty liver disease, announcing a $2.4B acquisition of 89bio to secure rights to…
In this Medscape commentary, Dr. Scott Kopetz of MD Anderson unpacks the rising role of ctDNA in colorectal cancer. Unlike…
Researchers at the University of Geneva have catalogued gut bacteria at the subspecies level and, with machine learning, trained a…
Medscape reports that oral GLP-1 drugs may reshape the obesity treatment landscape, but their true impact remains uncertain. With Novo…
The FDA has approved the Idylla CDx MSI test, a fully automated companion diagnostic for colorectal cancer that delivers results…